•  
  •  
  •  
  •  

2026-08-12 19:23:55

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Enviro Infra Engineers Reports 49.1% Revenue Growth to ₹ 3,592 Million in Q1 FY27; PAT Rises 6.5% to ₹ 452 Million
  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • Popular Vehicles & Services Reports 44.6% YoY Revenue Growth to ₹1,903.1 Crore in Q1 FY27; Turns Profitable with ₹1.4 Crore PAT
  • Hirect Limited Reports 20.3% Revenue Growth in Q1 FY27; Standalone Net Profit Up 17.8% Amid Global Expansion
  • Delton Cables reports highest ever first quarterly Revenue, EBITDA & PAT

Keywords Selected:  Unit1

Stock Report

  • NHPC commissions Unit 1 of Subansiri Lower HE Project
  • Lupin announces closure of Inspection by U.S. FDA at its Nagpur Unit-1 Facility with No Observations
  • 660 MW Unit-1 of SJVN's Buxar Thermal Power Project Successfully achieves Commercial Operation
  • NTPC arm commissions Unit 1 of Patratu STPP, Phase 1
  • Acknit Industries Ltd to close operations at Unit 1 in Falta Special Economic Zone
  • Fire at N R Agarwal Industries Limited's Unit I plant located at Vapi, Gujarat
  • Apitoria Pharma Pvt Ltd receives 5 observations from USFDA for API facility
  • SMS Lifesciences India Ltd receives EIR with VAI status from USFDA for API facility at Kazipally
  • Shilpa Pharma Lifesciences Limited, Unit-1, ANVISA Audit from Brazil
  • Shilpa Pharma Lifesciences Limited, Unit-1, Received EIR from USFDA
  • Closure of USFDA inspection at Zydus' API Unit 1 at Ankleshwar, Gujarat
  • USFDA Inspection at Unit-1 of Shilpa Pharma Lifesciences Limited
  • Lupin's Pithampur Unit-1 gets Form 483 from USFDA with 3 observations
  • Kwality Pharmaceuticals Ltd receives approval from DIGIMED, Peru for Generic, Injectable and OSD
  • Jubilant Ingrevia Ltd receives EIR from USFDA for Unit-1 at Bharuch
  • Concord Biotech Limited receives EUGMP certificate for Dholka facility
  • Neuland Laboratories Ltd's Unit 1 successfully completes USFDA inspection
  • ANVISA issues CGMP to Concord Biotech Ltd's Unit I
  • Shree Ajit Pulp and Paper Ltd resumes production process at Unit I
  • Lupin Receives EIR from U.S. FDA for its Nagpur Unit-1 Manufacturing Facility
  • SJVN Ltd's 60 MW NMHEP marches forward to the commissioning stage with Mechanical Spinning of Unit-I
  • NTPC commissions 800 MW of Unit 1 of Telangana STPP, Stage-I
  • Indsil Hydro Power and Manganese Ltd restarts operations of Unit 1
  • US FDA completes inspection at Unit I of Eugia Pharma Specialities Ltd

Latest Post

  • Enviro Infra Engineers Reports 49.1% Revenue Growth to ₹ 3,592 Million in Q1 FY27; PAT Rises 6.5% to ₹ 452 Million
  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • Popular Vehicles & Services Reports 44.6% YoY Revenue Growth to ₹1,903.1 Crore in Q1 FY27; Turns Profitable with ₹1.4 Crore PAT
  • Hirect Limited Reports 20.3% Revenue Growth in Q1 FY27; Standalone Net Profit Up 17.8% Amid Global Expansion
  • Delton Cables reports highest ever first quarterly Revenue, EBITDA & PAT


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025